arrow
D

David Marcoux

triana biomedicines
H指数:15
被引数:1,018

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TRI-611, a selective, brain-penetrant molecular glue degrader of ALK

TRI-611,一种选择性、可透过血脑屏障的ALK分子胶降解剂

Nature
IF48.5
2026-09-090
PRE
Discovery of Non-prostanoid EP4 Agonists for the Treatment of Inflammatory Bowel Disease

非前列腺素类EP4激动剂的发现及其在炎症性肠病治疗中的应用

2026-04-030
PRE
Tricyclic-Carbocyclic RORγt Inverse Agonists-Discovery of BMS-986313
2021-02-1612
PREAI
Aryl Ether-Derived Sphingosine-1-Phosphate Receptor (S1P1) Modulators: Optimization of the PK, PD, and Safety Profiles
2020-08-115
OAAI
Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist
2020-03-3137
OAAI
Rationally Designed, Conformationally Constrained Inverse Agonists of RORγt-Identification of a Potent, Selective Series with Biologic-Like in Vivo Efficacy
2019-10-2233
PREAI
Identification of a Potent, Selective, and Efficacious Phosphatidylinositol 3-Kinase δ (P13Kδ) Inhibitor for the Treatment of Immunological Disorders
2017-06-0517
PREAI
Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-34(R)-6-hexy1-5,6,7,8-tetrahydronaphthalen-2yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P1 Receptor Modulator
2016-12-0710
PREAI